RAPT Therapeutics, Inc. - COM (RAPT)

Historical Portfolio Holders from Q4 2019 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
31.8M
Holdings value Q2 2024
$97M
Value change Q2 2024
-$20.1M
Grand Portfolio weight change Q2 2024
0%
Number of holders
100
Number of buys Q2 2024
7
Number of sells Q2 2024
-4
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 385K $772K +$386K $2.01 14
2024 Q2 31.8M $97M -$20.1M $3.05 104
2024 Q1 31.9M $286M -$138M $8.98 122
2023 Q4 35M $869M +$6.74M $24.85 111
2023 Q3 34.8M $578M +$11.3M $16.62 98
2023 Q2 34.1M $637M +$14.4M $18.70 98
2023 Q1 33.3M $611M +$19.8M $18.35 104
2022 Q4 32.1M $635M +$67.4M $19.80 92
2022 Q3 30M $705M -$6.96M $24.06 95
2022 Q2 29.7M $543M +$30.1M $18.25 85
2022 Q1 28M $616M -$11.4M $21.99 82
2021 Q4 26.3M $966M +$58.6M $36.73 99
2021 Q3 24.8M $731M +$65.3M $31.05 108
2021 Q2 26.6M $846M +$180M $31.79 111
2021 Q1 21M $466M +$14.7M $22.20 81
2020 Q4 20.4M $404M +$1.19M $19.75 83
2020 Q3 16.8M $542M +$65.3M $32.20 67
2020 Q2 14.8M $430M +$93.9M $29.02 52
2020 Q1 11.7M $248M +$53.9M $21.27 37
2019 Q4 2.36M $64.4M +$64.4M $27.61 25